SciELO - Scientific Electronic Library Online

 
vol.148 issue7Cancer immunotherapy: an updateClassifications and scores used in digestive endoscopy author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista médica de Chile

Print version ISSN 0034-9887

Abstract

FONCEA, Camila et al. Osteonecrosis of the jaws. Rev. méd. Chile [online]. 2020, vol.148, n.7, pp.983-991. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872020000700983.

Medication-related osteonecrosis of the jaw is a disease where there is necrotic bone exposed or that can be explored by means of a fistula in the maxillofacial region. It has been associated with the use Biphosphonates and denosumab for osteoporosis. Although its etiology is unclear, it may be related to a decrease in bone turnover produced by these drugs, rendering the bone more prone to generate cell necrosis during invasive dental procedures, especially in the posterior region of the jaw. There is no consensus about the prevention and treatment of this condition. The aim of this paper is to present a review of the literature with the main characteristics of osteonecrosis of the jaws associated with drugs, together with a proposal for prevention and treatment for these patients.

Keywords : Osteonecrosis; Angiogenesis Inhibitors; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates.

        · text in Spanish     · Spanish ( pdf )